Nyxoah SA Ordinary Shares
Symbol: NYXH (NASDAQ)
5.58
▲ (0.18%) 0.010
Company Description:
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Key Stats
- Today's Open: $5.52
- Today's High: $5.618
- Today's Low: $5.56
- Today's Volume: 4.51K
- Yesterday Close: $5.57
- Yesterday High: $5.8
- Yesterday Low: $5.45
- Yesterday Volume: 49.92K
- Last Min Volume: 123
- Last Min High: $5.58
- Last Min Low: $5.58
- Last Min VWAP: $5.58
Company Profile
- Name: Nyxoah SA Ordinary Shares
- Website: https://www.nyxoah.com
- Listed Date: 2021-03-05
- Location: ,
- Market Status: Active
- CIK Number: 0001857190
- SIC Code:
- SIC description:
- Market Cap: $209.12M
- Round Lot: 100
- Outstanding Shares: 37.54M
- Asset Type: CS
RECENT FILINGS FOR NYXH
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 6-K | View |
| 2025-08-18 | 6-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 6-K | View |
| 2025-07-29 | 6-K | View |
| 2025-06-27 | 6-K | View |
| 2025-06-16 | 6-K | View |
| 2025-05-30 | 6-K | View |
| 2025-05-27 | 6-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-14 | 6-K | View |
| 2025-05-09 | 6-K | View |
| 2025-05-09 | 6-K | View |
| 2025-04-16 | 6-K | View |
| 2025-04-08 | 6-K | View |
| 2025-04-01 | EFFECT | View |
| 2025-03-28 | CORRESP | View |
| 2025-03-26 | UPLOAD | View |
| 2025-03-26 | 6-K | View |
| 2025-03-20 | F-3 | View |
Latest News on NYXH